A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
Clinical trial NCT04602624 · COMPLETED
Trial details
- NCT number
- NCT04602624
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-09-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.